Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce E Sands

Showing results (11-20 of 380) with videos related to

Pageof 38
Sort By:
The Surgical Clinics of North America|August 15, 2006
New therapies for the treatment of inflammatory bowel diseaseBruce E Sands
Gastroenterology|July 14, 2015
Biomarkers of Inflammation in Inflammatory Bowel DiseaseBruce E Sands
Digestive Diseases (Basel, Switzerland)|March 6, 2010
The placebo response rate in irritable bowel syndrome and inflammatory bowel diseaseBruce E Sands
The New England Journal of Medicine|December 26, 2019
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. ReplyBruce E Sands, Colleen Marano
Current Gastroenterology Reports|April 25, 2019
Novel Non-biologic Targets for Inflammatory Bowel DiseaseTushar Shukla, Bruce E Sands
Medicine and Health, Rhode Island|April 24, 2009
Epidemiology of inflammatory bowel disease and overview of pathogenesisBruce E Sands, Stacey Grabert
Journal of Clinical Gastroenterology|December 16, 2004
Acute appendicitis following colonoscopyMichael J Rosen, Bruce E Sands
Inflammatory Bowel Diseases|January 29, 2005
A survey of methodological variation in the Crohn's disease activity indexBruce E Sands, Choon Jin Ooi
Gastroenterology|June 27, 2025
ReplyRobert P Hirten, Bruce E Sands
Journal of Crohn'S & Colitis|May 13, 2022
Personalised Medicine with IL-23 Blockers: Myth or Reality?Zoë S Gottlieb, Bruce E Sands
Pageof 38

Showing results (11-20 of 380) with videos related to

Sort By:
Pageof 38
The Surgical Clinics of North America|August 15, 2006
New therapies for the treatment of inflammatory bowel diseaseBruce E Sands
Gastroenterology|July 14, 2015
Biomarkers of Inflammation in Inflammatory Bowel DiseaseBruce E Sands
Digestive Diseases (Basel, Switzerland)|March 6, 2010
The placebo response rate in irritable bowel syndrome and inflammatory bowel diseaseBruce E Sands
The New England Journal of Medicine|December 26, 2019
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. ReplyBruce E Sands, Colleen Marano
Current Gastroenterology Reports|April 25, 2019
Novel Non-biologic Targets for Inflammatory Bowel DiseaseTushar Shukla, Bruce E Sands
Medicine and Health, Rhode Island|April 24, 2009
Epidemiology of inflammatory bowel disease and overview of pathogenesisBruce E Sands, Stacey Grabert
Journal of Clinical Gastroenterology|December 16, 2004
Acute appendicitis following colonoscopyMichael J Rosen, Bruce E Sands
Inflammatory Bowel Diseases|January 29, 2005
A survey of methodological variation in the Crohn's disease activity indexBruce E Sands, Choon Jin Ooi
Gastroenterology|June 27, 2025
ReplyRobert P Hirten, Bruce E Sands
Journal of Crohn'S & Colitis|May 13, 2022
Personalised Medicine with IL-23 Blockers: Myth or Reality?Zoë S Gottlieb, Bruce E Sands
Pageof 38